Consistent with our prior results, we observed an increase in viable Paqr8-OE tumor cells, as well as a decrease in viable Paqr8-KO tumor cells, compared to controls following Her2 downregulation for 72 h (Fig. 7C, D). This evidence concerns the gene PAQR8 and neoplasm.